Literature DB >> 28623379

Cathelicidin-deficient mice exhibit increased survival and upregulation of key inflammatory response genes following cecal ligation and puncture.

Patricia Severino1, Suely Kubo Ariga2, Hermes Vieira Barbeiro2, Thais Martins de Lima2, Elisangela de Paula Silva1, Denise Frediani Barbeiro2, Marcel Cerqueira César Machado2, Victor Nizet3,4, Fabiano Pinheiro da Silva5,6.   

Abstract

Antimicrobial peptides possess a myriad of molecular properties including bacterial killing and the regulation of many aspects of innate immunity. Cathelicidins are a group of antimicrobial peptides widely investigated by the scientific community. Many studies have focused on the bactericidal and pro-inflammatory roles of cathelicidins. Because the role of endogenous cathelicidin expression remains obscure in deep-seated systemic infections, we induced sepsis in cathelicidin knockout and wild-type (WT) mice by cecal ligation and puncture, performing transcriptome screening by DNA microarray in conjunction with other immunologic assays. Cathelicidin-deficient mice showed increased survival compared to WT mice in this established experimental model of polymicrobial sepsis, in association with upregulation of certain key inflammatory response genes. Therefore, cathelicidins can exert both pro- and anti-inflammatory activities depending on the disease and cellular context. KEY MESSAGES: The role of cathelicidin in a CLP model is investigated using cathelicidin-KO mice. Cathelicidin-KO mice show an enhanced immune response and improved survival rates. An anti-inflammatory effect of cathelicidin is likely to be detrimental for CLP. Cathelicidin-KO mice show upregulation of genes associated with increased plasma levels of pro-inflammatory Ils. Cathelicidins appear to have both pro- and anti-inflammatory properties.

Entities:  

Keywords:  Cathelicidin; Gene expression; Inflammation; Sepsis

Mesh:

Substances:

Year:  2017        PMID: 28623379     DOI: 10.1007/s00109-017-1555-z

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  47 in total

Review 1.  Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity.

Authors:  Balaji Ramanathan; Elizabeth G Davis; Christopher R Ross; Frank Blecha
Journal:  Microbes Infect       Date:  2002-03       Impact factor: 2.700

Review 2.  The dual role of cathelicidins in systemic inflammation.

Authors:  Fabiano Pinheiro da Silva; Marcel Cerqueira César Machado
Journal:  Immunol Lett       Date:  2017-01-09       Impact factor: 3.685

3.  Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.

Authors:  Elizabeth S Danka; David A Hunstad
Journal:  J Infect Dis       Date:  2014-10-21       Impact factor: 5.226

Review 4.  Enterohemorrhagic and enteropathogenic Escherichia coli evolved different strategies to resist antimicrobial peptides.

Authors:  Jenny-Lee Thomassin; John R Brannon; Julienne Kaiser; Samantha Gruenheid; Herve Le Moual
Journal:  Gut Microbes       Date:  2012-08-16

5.  Human CD14 mediates recognition and phagocytosis of apoptotic cells.

Authors:  A Devitt; O D Moffatt; C Raykundalia; J D Capra; D L Simmons; C D Gregory
Journal:  Nature       Date:  1998-04-02       Impact factor: 49.962

6.  Endogenous intracellular cathelicidin enhances TLR9 activation in dendritic cells and macrophages.

Authors:  Yukinobu Nakagawa; Richard L Gallo
Journal:  J Immunol       Date:  2014-12-29       Impact factor: 5.422

7.  Antimicrobial peptide LL-37 promotes bacterial phagocytosis by human macrophages.

Authors:  Min Wan; Anne M van der Does; Xiao Tang; Lennart Lindbom; Birgitta Agerberth; Jesper Z Haeggström
Journal:  J Leukoc Biol       Date:  2014-02-18       Impact factor: 4.962

8.  The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease.

Authors:  Milan Chromek; Ida Arvidsson; Diana Karpman
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

Review 9.  Antimicrobial Peptides in Human Sepsis.

Authors:  Lukas Martin; Anne van Meegern; Sabine Doemming; Tobias Schuerholz
Journal:  Front Immunol       Date:  2015-08-20       Impact factor: 7.561

10.  Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo.

Authors:  Paula E Beaumont; Brian McHugh; Emily Gwyer Findlay; Annie Mackellar; Karen J Mackenzie; Richard L Gallo; John R W Govan; A John Simpson; Donald J Davidson
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

View more
  9 in total

Review 1.  Antimicrobial host defence peptides: functions and clinical potential.

Authors:  Neeloffer Mookherjee; Marilyn A Anderson; Henk P Haagsman; Donald J Davidson
Journal:  Nat Rev Drug Discov       Date:  2020-02-27       Impact factor: 84.694

2.  Cathelicidins Mitigate Staphylococcus aureus Mastitis and Reduce Bacterial Invasion in Murine Mammary Epithelium.

Authors:  Paloma Araujo Cavalcante; Cameron G Knight; Yi-Lin Tan; Ana Paula Alves Monteiro; Herman W Barkema; Eduardo R Cobo
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 3.  Cathelicidins: Immunomodulatory Antimicrobials.

Authors:  Roel M van Harten; Esther van Woudenbergh; Albert van Dijk; Henk P Haagsman
Journal:  Vaccines (Basel)       Date:  2018-09-14

4.  Cathelicidins and the Onset of Labour.

Authors:  Sara R van Boeckel; Lenka Hrabalkova; Tina L Baker; Heather MacPherson; Lorraine Frew; Ashley K Boyle; Brian J McHugh; Kirsten Wilson; Jane E Norman; Julia R Dorin; Donald J Davidson; Sarah J Stock
Journal:  Sci Rep       Date:  2019-05-14       Impact factor: 4.379

5.  Effects of Caloric Restriction with Protein Supplementation on Plasma Protein Profiles in Middle-Aged Women with Metabolic Syndrome-A Preliminary Open Study.

Authors:  Chia-Yu Chang; Yu-Tang Tung; Yen-Kuang Lin; Chen-Chung Liao; Ching-Feng Chiu; Te-Hsuan Tung; Amalina Shabrina; Shih-Yi Huang
Journal:  J Clin Med       Date:  2019-02-06       Impact factor: 4.241

6.  Cathelicidin protects mice from Rhabdomyolysis-induced Acute Kidney Injury.

Authors:  Beatriz Helena Cermaria Soares da Silva; Suely Kubo Ariga; Hermes Vieira Barbeiro; Rildo Aparecido Volpini; Denise Frediani Barbeiro; Antonio Carlos Seguro; Fabiano Pinheiro da Silva
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

Review 7.  Pulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment.

Authors:  Jiaqi Li; Huangliang Zheng; Sharon Shui Yee Leung
Journal:  Pharm Res       Date:  2022-09-19       Impact factor: 4.580

8.  Cathelicidin preserves intestinal barrier function in polymicrobial sepsis.

Authors:  Jeffery Ho; Hung Chan; Yonghao Liang; Xiaodong Liu; Lin Zhang; Qing Li; Yuchen Zhang; Judeng Zeng; Felix N Ugwu; Idy H T Ho; Wei Hu; Johnny C W Yau; Sunny H Wong; Wai Tat Wong; Lowell Ling; Chi H Cho; Richard L Gallo; Tony Gin; Gary Tse; Jun Yu; Matthew T V Chan; Czarina C H Leung; William K K Wu
Journal:  Crit Care       Date:  2020-02-10       Impact factor: 9.097

9.  Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients.

Authors:  Junyou Wang; Luqing Tong; Gaojun Lin; Hui Wang; Liang Zhang; Xuejun Yang
Journal:  BMC Cancer       Date:  2020-09-29       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.